Protocolized Initiation of Clonidine to Prevent Dexmedetomidine Withdrawal
Status:
Not yet recruiting
Trial end date:
2023-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the protocolized use of clonidine will reduce
dexmedetomidine withdrawal symptoms, reduce PICU length of stay, and reduce costs related to
sedation during hospital admission.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston